logo-loader
Callitas Health Inc.

Callitas Health names James Thompson president and CEO of the health and wellness company

Thomspon has been serving as interim chief after Gary Thompson stepped down for health reasons

Medicinal marijuana
Callitas recently welcomed a new chief medical cannabis advisor

Callitas Health Inc (CSE:LILY, OTCQB:MPHMF) announced that its interim CEO, James Thompson, will now be a permanent fixture at the head of the health and wellness company.

Thompson was also serving as interim president after former CEO Gary Thompson stepped down for health reasons. The new CEO was formerly the company’s chief operating officer before stepping up to fill the void.

READ: Callitas Health bolsters cannabis products business by hiring industry expert as advisor

“We look forward to where and how he expands the products and offerings of the company. He is a strong business leader and the right fit for Callitas as the company reaches new levels of expansion," said board member William Rodgers.

Callitas recently welcomed Dr. Gregory Smith, a medical expert well-versed in cannabinoid medication, as the firm’s chief medical cannabis advisor.

One of the clinical-stage company’s newest products included CannaMint Strips, a minty breath strip that offers users a discreet way to use cannabis.

Shares of the Ohio-based company were flat at US$0.18 in Thursday pre-market trading.

Quick facts: Callitas Health Inc.

Price: $0.11

Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 04/25/2019

2 min read